Reunion envisions a day when depression isn’t just managed, it’s curable. That’s why we relentlessly pursue the development of safer and more accessible therapeutics. As an early-stage pharmaceutical company, we’re focused on pushing the boundaries of neuroscience to develop new and improved options for the millions of people whose needs are not met by the current standard of care.